DOI: http://dx.doi.org/10.18203/2349-3933.ijam20195248

Study of nonalcoholic fatty liver Telangana population

Parth N. Patel, Mohd Ifthekhar Mohiuddin

Abstract


Background: Among 83 patients of both sexes aged between 25 to 65 adults had NAFLD with metabolic syndrome were studied.

Methods: U.S.G. biochemical study included total cholesterol, AST, ALP, S, Albumin total Bilirubin, FBS, HbA1c and blood pressure was recorded.

Results: Among 16(19.2%) had grade-I (mild steatosis) 38(45.7%) had grade-II (Moderate steatosis), 29(34.9%) had grade-III (severe steatosis), The clinical manifestation were 49(59%) had BMI 22.8 to 23.2, 34(40.9%) had BMI 23.3 to 24.2. D.M status was 33(39.7%) were pre-diabetic, 50(60.2%) were diabetic mellitus. 19(22.8%) were norma- tensive, 64(77.1%) were hypertensive, 63(75.9%) were hyperlipidemic, 23(27.7%) had IHD. 4(4.81%) had MI. Mean value of total cholesterol was 223±9.2, Triglyceride 24.8±13.3, HDL 42.3±2.5, LDL 128±13.8, AST 52.8±3.6, ALT 67.2±6.8, ALP 107±11.8, S. Albumin 3.50±0.12, Total bilirubin 0.93±0.10, FBS 13.±12.2, HB A/c 9.10±402.

Conclusions: The present study of NAFLD was performed by combination of radiological and laboratory techniques, greatly reducing the requirement for invasive biopsy and reduce the morbidity and mortality.


Keywords


Diabetes mellitus, Metabolic syndrome, Non-alcoholics fatty liver disease, Non-alcoholics steatohepatitis

Full Text:

PDF

References


Ludwig J. Steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. In Mayo Clin Proc. 1980;55:434-8.

Vuppalanchi R, Chalasani N. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management. Hepatol. 2009;49(1):306-17.

Gupta P, Amarapurkar D, Agals S, Baijal R, Kulshreshta P, Pramanik S, et al. Non Alcoholic fatty liver disease in type-II diabetes mellitus. J Gastroenterol Hepatol. 2004;19(8):854-8.

Petta S, Muratore C, Craxi A. Non-alcoholic fatty liver disease pathogenesis: the present and the future. Dige Liver Dis. 2009;41(9):615-25.

Dowman JK, Tomlinson JW, Newsome PN. Pathogenesis of non-alcoholic fatty liver disease. QJM: An Int J Medi. 2009;103(2):71-83.

Cheung O, Kapoor A, Puri P, Sistrun S, Luketic VA, Sargeant CC, et al. The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndrome. Hepatol. 2007;46(4):1091-100.

Duseja A. Non-alcoholic fatty liver disease in India-a lot done, yet more required! Ind J Gastroenterol. 2010;29(6):217-25.

Agarwal SR, Malhotra V, Sakhuja P, Sarin SK. Clinical, biochemical and histological profile of non-alcoholic steatohepatitis. Indi J Gastroenterol: offici J Indi Soci Gastroenterol. 2001;20(5):183-6.

Day CP. From fat to inflammation. Gastroenterol. 2006;130(1):207-10.

Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatol. 2004;40(6):1387-95.

Loria P, Carulli L, Bertolotti M, Lonardo A. Endocrine and liver interaction: the role of endocrine pathways in NASH. Nature Reviews Gastroenterol Hepatol. 2009;6(4):236.